Trial · NCT03548935
Outcomes42
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 42
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Body Weight (%) | Baseline (week 0) to week 68 | Overall number of participants analyzed = full analysis set (FAS) which comprised all randomized participants. Number Analyzed = number of participants with available data. | Percentage point | MEAN |
| PRIMARY | Participants Who Achieve 5 or More Percent Body Weight Reduction (Yes/no) | After week 68 | Overall number of participants analyzed = full analysis set (FAS) which comprised all randomized participants. Number Analyzed = number of participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Subjects Who Achieve 10 or More Percent Body Weight Reduction (Yes/no) | Week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Participants Who Achieve 15 or More Percent Body Weight Reduction (Yes/no) | Week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Participants Who Achieve 20 or More Percent Body Weight Reduction (Yes/no) | Week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change in Waist Circumference (cm) | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Centimeter (cm) | MEAN |
| SECONDARY | Change in Systolic Blood Pressure (mmHg) | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Millimeters of mercury (mmHg) | MEAN |
| SECONDARY | Change in Short Form 36 (SF-36) | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Score on a scale | MEAN |
| SECONDARY | Change in Impact of Weight on Quality of Life-Lite for Clinical Trial (IWQoL-Lite for CT) Score | Baseline (week 0) to week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | Score on a scale | MEAN |
| SECONDARY | Change in Body Weight (kg) | Baseline (week 0) to week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | Kilogram (kg) | MEAN |
| SECONDARY | Change in Body Mass Index (BMI) (kg/m2) | Baseline (week 0) to week 68 | Overall number of participants analyzed = full analysis set (FAS) which comprised all randomized participants. Number Analyzed = number of participants with available data. | Kilogram per square meter (kg/sqm) | MEAN |
| SECONDARY | Change in HbA1C (%) | Baseline (week 0) to week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | Percentage point of HbA1c | MEAN |
| SECONDARY | Change in HbA1C (mmol/Mol) | Baseline (week 0) to week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | millimoles per mole (mmol/mol) | MEAN |
| SECONDARY | Change in Fasting Plasma Glucose (FPG) (mg/dL) | Baseline (week 0) to week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | milligrams per deciliter (mg/dL) | MEAN |
| SECONDARY | Change in Fasting Serum Insulin (mIU/L) - Ratio to Baseline | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Ratio of fasting serum insulin | GEOMETRIC_MEAN |
| SECONDARY | Change in Diastolic Blood Pressure (mmHg) | Baseline (week 0) to week 68 | FAS included all randomized participants. 'Overall Number of Participants Analyzed' = participants with available data. | Millimeters of mercury (mmHg) | MEAN |
| SECONDARY | Change in Total Cholesterol (mg/dL) - Ratio to Baseline | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Ratio of total cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in High-density Lipoproteins (HDL) (mg/dL) - Ratio to Baseline | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Ratio of HDL cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in Low-density Lipoproteins (LDL) (mg/dL) - Ratio to Baseline | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Ratio of LDL cholesterol | GEOMETRIC_MEAN |
| SECONDARY | Change in Very Low-density Lipoproteins (VLDL) (mg/dL) - Ratio to Baseline | Baseline (week 0) to week 68 | FAS included all randomised participants. 'Overall Number of Participants Analyzed' = participants with available data. | Ratio of VLDL cholesterol | GEOMETRIC_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03548935/outcomes